| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2005Sci...309.1380P |
| P356 | DOI | 10.1126/SCIENCE.1113401 |
| P3181 | OpenCitations bibliographic resource ID | 1545002 |
| P698 | PubMed publication ID | 16123302 |
| P5875 | ResearchGate publication ID | 7637988 |
| P2093 | author name string | Zhong Guo | |
| Kui Shin Voo | |||
| Rong-Fu Wang | |||
| Yanchun Li | |||
| Helen Y Wang | |||
| Tihui Fu | |||
| Yukiko Kiniwa | |||
| Guangyong Peng | |||
| Daniel Y Wang | |||
| Weiyi Peng | |||
| P433 | issue | 5739 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | positive regulation of innate immune response | Q14905524 |
| cell function | Q95674809 | ||
| toll-like receptor | Q408004 | ||
| Toll like receptor 8 | Q4459747 | ||
| P304 | page(s) | 1380-4 | |
| P577 | publication date | 2005-08-26 | |
| P1433 | published in | Science | Q192864 |
| P1476 | title | Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function | |
| P478 | volume | 309 |
| Q43163965 | 3-Methylcholanthrene-induced transforming growth factor-beta-producing carcinomas, but not sarcomas, are refractory to regulatory T cell-depletion therapy |
| Q39698048 | A Novel R848-Conjugated Inactivated Influenza Virus Vaccine Is Efficacious and Safe in a Neonate Nonhuman Primate Model |
| Q34015759 | A potential protein adjuvant derived from Mycobacterium tuberculosis Rv0652 enhances dendritic cells-based tumor immunotherapy |
| Q35192409 | A single naturally occurring 2'-O-methylation converts a TLR7- and TLR8-activating RNA into a TLR8-specific ligand |
| Q36307323 | Activation of the mammalian immune system by siRNAs. |
| Q43258243 | Activation profile of Toll-like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus. |
| Q37173798 | Activation requirements and responses to TLR ligands in human CD4+ T cells: comparison of two T cell isolation techniques |
| Q36442637 | Acute Exposure to Tris(1,3-dichloro-2-propyl) Phosphate (TDCIPP) Causes Hepatic Inflammation and Leads to Hepatotoxicity in Zebrafish |
| Q33299427 | Administration of a CD25-directed immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivo |
| Q36988746 | Advancements in immune tolerance |
| Q36983216 | Airway house dust extract exposures modify allergen-induced airway hypersensitivity responses by TLR4-dependent and independent pathways |
| Q41931711 | An R848 adjuvanted influenza vaccine promotes early activation of B cells in the draining lymph node of nonhuman primate neonates. |
| Q34431983 | An intranasally delivered Toll-like receptor 7 agonist elicits robust systemic and mucosal responses to Norwalk virus-like particles |
| Q28085673 | Archaea associated with human surfaces: not to be underestimated |
| Q35901282 | Association of cervical cancer with the presence of CD4+ regulatory T cells specific for human papillomavirus antigens. |
| Q33955372 | Association pattern of interleukin-1 receptor-associated kinase-4 gene polymorphisms with allergic rhinitis in a Han Chinese population |
| Q36385481 | Autoimmunity in coxsackievirus B3 induced myocarditis |
| Q37022838 | B7-1/B7-2 blockade overrides the activation of protective CD8 T cells stimulated in the absence of Foxp3+ regulatory T cells |
| Q37815276 | Bacterial infections, alloimmunity, and transplantation tolerance |
| Q54962852 | Baicalein and baicalin inhibit colon cancer using two distinct fashions of apoptosis and senescence. |
| Q38848213 | Biological Response Modifier in Cancer Immunotherapy |
| Q41009948 | Blocking Indolamine-2,3-Dioxygenase Rebound Immune Suppression Boosts Antitumor Effects of Radio-Immunotherapy in Murine Models and Spontaneous Canine Malignancies. |
| Q38542113 | Brain Tumor Immunotherapy: What have We Learned so Far? |
| Q26744624 | Breaking Free of Control: How Conventional T Cells Overcome Regulatory T Cell Suppression |
| Q36710590 | Burkholderia pseudomallei infection of T cells leads to T-cell costimulation partially provided by flagellin |
| Q36232078 | CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome |
| Q43745676 | CD4+Foxp3+ regulatory T-cell impairment by paclitaxel is independent of toll-like receptor 4. |
| Q34768139 | CD8+ T-cell memory in tumor immunology and immunotherapy |
| Q37892578 | CDX-1307: a novel vaccine under study as treatment for muscle-invasive bladder cancer. |
| Q37785836 | Cancer Immunotherapy and Nanomedicine |
| Q60938527 | Cancer Stem Cells and Immunosuppressive Microenvironment in Glioma |
| Q51964906 | Circumvention of regulatory CD4(+) T cell activity during cross-priming strongly enhances T cell-mediated immunity. |
| Q34675128 | Combined TLR7/8 and TLR9 ligands potentiate the activity of a Schistosoma japonicum DNA vaccine |
| Q37267529 | Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses |
| Q42780048 | Commensal microbiota drive proliferation of conventional and Foxp3(+) regulatory CD4(+) T cells in mesenteric lymph nodes and Peyer's patches |
| Q36057441 | Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer |
| Q42918751 | Contribution of TLR signaling to the pathogenesis of colitis-associated cancer in inflammatory bowel disease |
| Q51144432 | Controlled release of antigen and Toll-like receptor ligands from PLGA nanoparticles enhances immunogenicity. |
| Q39832786 | Controlling T cell senescence in the tumor microenvironment for tumor immunotherapy |
| Q35047326 | Coordinated gene expression of Th17- and Treg-associated molecules correlated with resolution of the monophasic experimental autoimmune uveitis. |
| Q36885368 | Coordinating TLR-activated signaling pathways in cells of the immune system |
| Q34591024 | Coordination of early protective immunity to viral infection by regulatory T cells |
| Q59477539 | Costimulatory and coinhibitory immune checkpoint receptors in head and neck cancer: unleashing immune responses through therapeutic combinations |
| Q35776179 | CpG DNA inhibits CD4+CD25+ Treg suppression through direct MyD88-dependent costimulation of effector CD4+ T cells |
| Q37565174 | CpG oligodeoxynucleotide ligand potentiates the activity of the pVAX1-Sj26GST. |
| Q38204912 | Crucial Role of Viral Reactivation in the Development of Severe Drug Eruptions: a Comprehensive Review |
| Q35215158 | Current advances in T-cell-based cancer immunotherapy |
| Q41160055 | Cutaneous RANK-RANKL Signaling Upregulates CD8-Mediated Antiviral Immunity during Herpes simplex Virus Infection by Preventing Virus-Induced Langerhans Cell Apoptosis |
| Q41807164 | Dendritic cells matured in the presence of TLR ligands overcome the immunosuppressive functions of regulatory T cells |
| Q37547414 | Development of virus-specific CD4+ and CD8+ regulatory T cells induced by human herpesvirus 6 infection |
| Q37482390 | Developmental biology of the innate immune response: implications for neonatal and infant vaccine development |
| Q36389463 | Differential constitutive and cytokine-modulated expression of human Toll-like receptors in primary neutrophils, monocytes, and macrophages |
| Q51901055 | Differential expression of Toll-like receptors in follicular lymphoma, diffuse large B-cell lymphoma and peripheral T-cell lymphoma. |
| Q58633980 | Diminished TLR2-TLR9 mediated CD4+ T cell responses are associated with increased inflammation in intraocular tuberculosis |
| Q35285757 | Direct Toll-Like Receptor 8 signaling increases the functional avidity of human CD8+ T lymphocytes generated for adoptive T cell therapy strategies |
| Q47911048 | Direct recognition of LPS by human but not murine CD8+ T cells via TLR4 complex |
| Q36471827 | Directions in the immune targeting of cancer: lessons learned from the cancer-testis Ag NY-ESO-1. |
| Q89994291 | Double-faced implication of CD4+ Foxp3+ regulatory T cells expanded by acute dengue infection via TLR2/MyD88 pathway |
| Q36293678 | Effects of Toll-like receptor signals in T-cell neoplasms |
| Q40332702 | Effects of adenoviral gene transfer of mutated IkappaBalpha, a novel inhibitor of NF-kappaB, on human monocyte-derived dendritic cells |
| Q36486882 | Emerging possibilities in the development and function of regulatory T cells |
| Q36580095 | Endogenous TLR ligands and autoimmunity |
| Q34611787 | Engagement of TLR2 does not reverse the suppressor function of mouse regulatory T cells, but promotes their survival |
| Q35027578 | Engagement of TLR2 reverses the suppressor function of conjunctiva CD4+CD25+ regulatory T cells and promotes herpes simplex virus epitope-specific CD4+CD25- effector T cell responses |
| Q48379910 | Enhancement of glioma-specific immunity in mice by "NOBEL", an insulin-like growth factor 1 receptor antisense oligodeoxynucleotide |
| Q37139813 | Enhancing cancer immunotherapy by intracellular delivery of cell-penetrating peptides and stimulation of pattern-recognition receptor signaling |
| Q40316208 | Epstein-Barr virus (EBV) latent membrane protein-1-specific cytotoxic T lymphocytes targeting EBV-carrying natural killer cell malignancies. |
| Q57477472 | Establishment of a novel safety assessment method for vaccine adjuvant development |
| Q36557953 | Exploitation of the Toll-like receptor system in cancer: a doubled-edged sword? |
| Q43429839 | Expression and function of toll-like receptor 8 and Tollip in colonic epithelial cells from patients with inflammatory bowel disease |
| Q43628018 | Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis |
| Q33951920 | Expression of the autoimmune susceptibility gene FcRL3 on human regulatory T cells is associated with dysfunction and high levels of programmed cell death-1. |
| Q28595156 | Extrinsic MAVS signaling is critical for Treg maintenance of Foxp3 expression following acute flavivirus infection |
| Q36494499 | Feeding our immune system: impact on metabolism |
| Q46215374 | Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression |
| Q37972689 | Foxp3(+) regulatory T cells, immune stimulation and host defence against infection |
| Q35175744 | Foxp3+ regulatory T cells impede the priming of protective CD8+ T cells. |
| Q26865532 | From tumor immunosuppression to eradication: targeting homing and activity of immune effector cells to tumors |
| Q36673290 | Functional dynamics of naturally occurring regulatory T cells in health and autoimmunity. |
| Q42941731 | GITR Blockade Facilitates Treg Mediated Allograft Survival |
| Q42241048 | Gene expression analysis in children with complex seizures due to influenza A(H1N1)pdm09 or rotavirus gastroenteritis. |
| Q104795077 | Glucose metabolism characteristics and TLR8-mediated metabolic control of CD4+ Treg cells in ovarian cancer cells microenvironment |
| Q34550753 | Granzyme A produced by γ(9)δ(2) T cells induces human macrophages to inhibit growth of an intracellular pathogen. |
| Q35755201 | Gut feelings of safety: tolerance to the microbiota mediated by innate immune receptors |
| Q36861242 | HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism |
| Q28088598 | Harnessing the Microbiome to Enhance Cancer Immunotherapy |
| Q44688219 | Helicobacter pylori induces in-vivo expansion of human regulatory T cells through stimulating interleukin-1β production by dendritic cells |
| Q36049894 | Hepatocellular carcinoma and macrophage interaction induced tumor immunosuppression via Treg requires TLR4 signaling |
| Q36330959 | High-dimensional gene expression profiling studies in high and low responders to primary smallpox vaccination |
| Q37098709 | High-frequency haplotypes in the X chromosome locus TLR8 are associated with both CD and UC in females |
| Q90740831 | Human labour is associated with altered regulatory T cell function and maternal immune activation |
| Q36220716 | Human regulatory T cells induce T-lymphocyte senescence |
| Q36916400 | Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells |
| Q54427491 | Human tumor antigen-specific helper and regulatory T cells share common epitope specificity but exhibit distinct T cell repertoire. |
| Q51887184 | Human tumor-infiltrating Th17 cells have the capacity to differentiate into IFN-γ+ and FOXP3+ T cells with potent suppressive function. |
| Q42370805 | IFN-γ alters the expression of diverse immunity related genes in a cell culture model designed to represent maturing neutrophils. |
| Q40135212 | Identification of a novel NY-ESO-1 promiscuous helper epitope presented by multiple MHC class II molecules found frequently in the Japanese population |
| Q35954674 | Imbalance in distribution of functional autologous regulatory T cells in rheumatoid arthritis |
| Q28972540 | Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor Ligands |
| Q89493861 | Immune System Sex Differences May Bridge the Gap Between Sex and Gender in Fibromyalgia |
| Q36593747 | Immune resistance orchestrated by the tumor microenvironment |
| Q41869061 | Immunogenic, but not steady-state, antigen presentation permits regulatory T-cells to control CD8+ T-cell effector differentiation by IL-2 modulation. |
| Q55669682 | Immunological Mechanisms in Allergic Diseases and Allergen Tolerance: The Role of Treg Cells. |
| Q28510289 | Immunomodulatory effects associated with a live vaccine against Leishmania major containing CpG oligodeoxynucleotides |
| Q36626285 | Immunopathogenesis of IBD: insufficient suppressor function in the gut? |
| Q38154151 | Immunosuppressive networks and checkpoints controlling antitumor immunity and their blockade in the development of cancer immunotherapeutics and vaccines. |
| Q29636247 | Immunosuppressive strategies that are mediated by tumor cells |
| Q84978571 | In vitro lipopolysaccharide treatment alters regulatory T cell properties in chickens |
| Q34691545 | In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines. |
| Q33931622 | In vivo delivery of antigens by adenovirus dodecahedron induces cellular and humoral immune responses to elicit antitumor immunity |
| Q30414501 | Inflammation and Gliomagenesis: Bi-Directional Communication at Early and Late Stages of Tumor Progression |
| Q40777442 | Inflammation promotes the loss of adeno-associated virus-mediated transgene expression in mouse liver. |
| Q42945799 | Influence of tumors on protective anti-tumor immunity and the effects of irradiation. |
| Q37297514 | Inhibition of CD4+CD25+ regulatory T cell function and conversion into Th1-like effectors by a Toll-like receptor-activated dendritic cell vaccine |
| Q47743642 | Innate immune response gene expression profiles characterize primary antiphospholipid syndrome. |
| Q38118170 | Innate immune responses in the CNS: role of toll-like receptors, mechanisms, and therapeutic opportunities in multiple sclerosis |
| Q36800979 | Innate immunity of the newborn: basic mechanisms and clinical correlates |
| Q38240851 | Insights into the Relationship between Toll Like Receptors and Gamma Delta T Cell Responses |
| Q37777344 | Insights into the role of Toll-like receptors in modulation of T cell responses |
| Q33496328 | Integrative modeling of transcriptional regulation in response to antirheumatic therapy |
| Q84215298 | Interferon-alpha regulates the dynamic balance between human activated regulatory and effector T cells: implications for antiviral and autoimmune responses |
| Q90066938 | Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies |
| Q80972826 | Involvement of cellular death in TRAIL/DR5-dependent suppression induced by CD4(+)CD25(+) regulatory T cells |
| Q26858856 | Ischemia reperfusion control: the key of kidney graft outcome |
| Q37091343 | Jmjd3 inhibits reprogramming by upregulating expression of INK4a/Arf and targeting PHF20 for ubiquitination |
| Q28510808 | LPS-induced TNF-alpha factor (LITAF)-deficient mice express reduced LPS-induced cytokine: Evidence for LITAF-dependent LPS signaling pathways |
| Q45966062 | Lactobacillus reuteri promotes Helicobacter hepaticus-associated typhlocolitis in gnotobiotic B6.129P2-IL-10(tm1Cgn) (IL-10(-/-) ) mice. |
| Q37073695 | Ligation of TLR9 induced on human IL-10-secreting Tregs by 1alpha,25-dihydroxyvitamin D3 abrogates regulatory function. |
| Q98771555 | Lipidation Approaches Potentiate Adjuvant-Pulsed Immune Surveillance: A Design Rationale for Cancer Nanovaccine |
| Q40503533 | MALT1 is an intrinsic regulator of regulatory T cells. |
| Q41996270 | Malignant B cells skew the balance of regulatory T cells and TH17 cells in B-cell non-Hodgkin's lymphoma |
| Q35886583 | Mechanisms and pathways of innate immune activation and regulation in health and cancer |
| Q39454807 | Metabolism-associated danger signal-induced immune response and reverse immune checkpoint-activated CD40+ monocyte differentiation |
| Q36115730 | Microbe-dendritic cell dialog controls regulatory T-cell fate |
| Q40227012 | Microbial infection-induced expansion of effector T cells overcomes the suppressive effects of regulatory T cells via an IL-2 deprivation mechanism |
| Q35901034 | Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling. |
| Q90461434 | Microbiome Profile of Deep Endometriosis Patients: Comparison of Vaginal Fluid, Endometrium and Lesion |
| Q33839116 | Microbiota, Inflammation and Colorectal Cancer |
| Q38868855 | Modulating the innate immune activity in murine tumor microenvironment by a combination of inducer molecules attached to microparticles |
| Q37686558 | Modulation of immune responses through direct activation of Toll-like receptors to T cells |
| Q37805517 | Modulation of toll-like receptor function has therapeutic potential in autoimmune disease |
| Q37034196 | Mouse gammadelta T cells are capable of expressing MHC class II molecules, and of functioning as antigen-presenting cells |
| Q24309046 | NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways |
| Q34359613 | NOD1 cooperates with TLR2 to enhance T cell receptor-mediated activation in CD8 T cells |
| Q34219556 | Neural injury following stroke: are Toll-like receptors the link between the immune system and the CNS? |
| Q56880715 | Nucleic acid agonists for Toll-like receptor 7 are defined by the presence of uridine ribonucleotides |
| Q42220060 | Nucleic acid sensing by T cells initiates Th2 cell differentiation |
| Q34477650 | OX40 costimulation can abrogate Foxp3+ regulatory T cell-mediated suppression of antitumor immunity |
| Q36586115 | Oligodeoxynucleotides expressing polyguanosine motifs promote antitumor activity through the upregulation of IL-2. |
| Q35891619 | Oligodeoxynucleotides stabilize Helios-expressing Foxp3+ human T regulatory cells during in vitro expansion |
| Q33909195 | Oral vaccination with attenuated Salmonella enterica strains encoding T-cell epitopes from tumor antigen NY-ESO-1 induces specific cytotoxic T-lymphocyte responses |
| Q28081922 | Origin and functions of pro-inflammatory cytokine producing Foxp3+ regulatory T cells |
| Q84961071 | Overexpression of Toll-like receptor 2/4 on monocytes modulates the activities of CD4(+)CD25(+) regulatory T cells in chronic hepatitis B virus infection |
| Q43051932 | Overexpression of Toll-like receptor 8 correlates with the progression of podocyte injury in murine autoimmune glomerulonephritis. |
| Q33979892 | Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis |
| Q42092171 | Pathogenic and protective roles of MyD88 in leukocytes and epithelial cells in mouse models of inflammatory bowel disease. |
| Q36750331 | Pattern recognition receptors in microbial keratitis |
| Q57492837 | Photochemical Treatment of APCs Can Eliminate Associated Viruses and Maintain the APC Function for Generating Antigen-Specific CTLs Ex Vivo |
| Q35699010 | Plasmacytoid dendritic cells lead the charge against tumors |
| Q45093751 | Polymorphisms within Toll-like receptors are associated with systemic lupus erythematosus in a cohort of Danish females |
| Q35213554 | Polyubiquitin binding to ABIN1 is required to prevent autoimmunity |
| Q34242591 | Positive T cell co-stimulation by TLR7/8 ligands is dependent on the cellular environment |
| Q34491734 | Profound tumor-specific Th2 bias in patients with malignant glioma |
| Q80216688 | Proportion of peripheral blood and decidual CD4(+) CD25(bright) regulatory T cells in pre-eclampsia |
| Q36536645 | Prospects for recombinant vaccines against Babesia bovis and related parasites |
| Q45964186 | Randomized phase 2/3 trial of CpG oligodeoxynucleotide PF-3512676 alone or with dacarbazine for patients with unresectable stage III and IV melanoma. |
| Q37084884 | Regulation of T-cell migration and effector functions: insights from in vivo imaging studies |
| Q36727307 | Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors |
| Q21131435 | Regulatory T cell suppressive potency dictates the balance between bacterial proliferation and clearance during persistent Salmonella infection |
| Q33798158 | Regulatory T cells and Toll-like receptors: what is the missing link? |
| Q36534827 | Regulatory T cells and innate immune regulation in tumor immunity |
| Q36570665 | Regulatory T cells and systemic lupus erythematosus. |
| Q37248735 | Regulatory T cells and the immune pathogenesis of prenatal infection |
| Q36969926 | Regulatory T cells and toll-like receptors: regulating the regulators |
| Q84073243 | Regulatory T cells in cancer |
| Q34547120 | Regulatory T cells in experimental autoimmune disease |
| Q37961175 | Regulatory T cells in infection |
| Q36549731 | Regulatory T cells in microbial infection |
| Q36563550 | Regulatory T cells in virus infections |
| Q37412624 | Regulatory T cells overturned: the effectors fight back |
| Q36563545 | Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation |
| Q48231687 | Regulatory T cells trigger effector T cell DNA damage and senescence caused by metabolic competition |
| Q36982171 | Regulatory T cells: potential target in anticancer immunotherapy |
| Q38202988 | Regulatory T-cell homeostasis: steady-state maintenance and modulation during inflammation |
| Q37302327 | Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment? |
| Q38637362 | Regulatory T-cells and preeclampsia: an overview of literature |
| Q88008277 | Regulatory functions of γδ T cells |
| Q46934849 | Regulatory-T-cell inhibition versus depletion: the right choice in cancer immunotherapy |
| Q52655916 | Required role of apoptotic myogenic precursors and toll-like receptor stimulation for the establishment of autoimmune myositis in experimental murine models. |
| Q35044185 | Requirements for prolongation of allograft survival with regulatory T cell infusion in lymphosufficient hosts |
| Q34700325 | Resiquimod and other immune response modifiers as vaccine adjuvants |
| Q35288713 | Resistance to regulatory T cell-mediated suppression in rheumatoid arthritis can be bypassed by ectopic foxp3 expression in pathogenic synovial T cells |
| Q90577375 | Resolution of uveitis |
| Q35161570 | Retracted: Genetic Polymorphism of Interferon Regulatory Factor 5 (IRF5) Correlates with Allograft Acute Rejection of Liver Transplantation |
| Q37754767 | Role of Toll-like receptors in transplantation tolerance |
| Q28246233 | Role of toll-like receptors in cervical, endometrial and ovarian cancers: a review |
| Q38163493 | Role of toll-like receptors in liver transplantation |
| Q26853280 | Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions |
| Q52329737 | SALL1 functions as a tumor suppressor in breast cancer by regulating cancer cell senescence and metastasis through the NuRD complex. |
| Q37336304 | Safety and efficacy of neonatal vaccination |
| Q38770847 | Seafood allergen-induced hypersensitivity at the microbiota-mucosal site: Implications for prospective probiotic use in allergic response regulation |
| Q51968876 | Selective blockade of NF-kappaB by novel mutated IkappaBalpha suppresses CD3/CD28-induced activation of memory CD4+ T cells in asthma. |
| Q89969652 | Senescent T cells within suppressive tumor microenvironments: emerging target for tumor immunotherapy |
| Q92527135 | Sensing of HIV-1 by TLR8 activates human T cells and reverses latency |
| Q43258134 | Signaling through TLR7 enhances the immunosuppressive activity of murine CD4+CD25+ T regulatory cells |
| Q37043735 | Special regulatory T cell review: The resurgence of the concept of contrasuppression in immunoregulation |
| Q37238831 | Specific recruitment of γδ regulatory T cells in human breast cancer. |
| Q34516619 | Spontaneous production of immunoglobulin M in human epithelial cancer cells |
| Q57198394 | Strategies to Stimulate Innate Immunity for Designing Effective Vaccine Adjuvants |
| Q36499083 | T cell expression of MyD88 is required for resistance to Toxoplasma gondii |
| Q37454346 | T-regulatory cell modulation: the future of cancer immunotherapy? |
| Q37168023 | T-regulatory cells in systemic lupus erythematosus |
| Q41997055 | TLR Agonists as Adjuvants for Cancer Vaccines. |
| Q38195599 | TLR Agonists for Cancer Immunotherapy: Tipping the Balance between the Immune Stimulatory and Inhibitory Effects |
| Q36850457 | TLR agonists: our best frenemy in cancer immunotherapy |
| Q37051003 | TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours |
| Q34580904 | TLR-2 activation induces regulatory T cells and long-term suppression of asthma manifestations in mice. |
| Q34400322 | TLR-based immune adjuvants. |
| Q37957689 | TLR-dependent T cell activation in autoimmunity. |
| Q52649195 | TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy. |
| Q58581671 | TLR2 engagement on CD8 T cells lowers the thresholdfor optimal antigen-induced T cell activation |
| Q36456469 | TLR2 ligation protects effector T cells from regulatory T-cell mediated suppression and repolarizes T helper responses following MVA-based cancer immunotherapy. |
| Q37266980 | TLR2-independent induction and regulation of chronic intestinal inflammation. |
| Q40157170 | TLR7 Signaling Regulates Th17 Cells and Autoimmunity: Novel Potential for Autoimmune Therapy |
| Q80404457 | TLR7 stimulation augments T effector-mediated rejection of skin expressing neo-self antigen in keratinocytes |
| Q34880391 | TLR8 signaling enhances tumor immunity by preventing tumor-induced T-cell senescence |
| Q39150078 | TLR8 stimulation enhances cetuximab-mediated natural killer cell lysis of head and neck cancer cells and dendritic cell cross-priming of EGFR-specific CD8+ T cells |
| Q57815155 | TLR8-Mediated Metabolic Control of Human Treg Function: A Mechanistic Target for Cancer Immunotherapy |
| Q56940858 | TLR8-mediated NF-κB and JNK Activation Are TAK1-independent and MEKK3-dependent |
| Q33731098 | TLR8-mediated activation of human monocytes inhibits TL1A expression |
| Q36478446 | TLR9 engagement on CD4 T lymphocytes represses gamma-radiation-induced apoptosis through activation of checkpoint kinase response elements |
| Q36526346 | TLR9 in health and disease |
| Q92123390 | TLRs in pulmonary diseases |
| Q47570715 | TLRs/NLRs: Shaping the landscape of host immunity. |
| Q39246438 | TRAIL suppresses tumor growth in mice by inducing tumor-infiltrating CD4(+)CD25 (+) Treg apoptosis |
| Q39657141 | Targeted microbeads for attraction and induction of specific innate immune response in the tumor microenvironment |
| Q35141490 | Targeting of TLRs inhibits CD4+ regulatory T cell function and activates lymphocytes in human peripheral blood mononuclear cells |
| Q37991536 | Targeting pattern recognition receptors in cancer immunotherapy. |
| Q37983467 | Targeting regulatory T cells |
| Q27022348 | Targeting regulatory T cells in cancer |
| Q64250654 | The Relationship between Toll-like Receptors and -Related Gastropathies: Still a Controversial Topic |
| Q47704782 | The Role of Toll-Like Receptors and Vitamin D in Cardiovascular Diseases-A Review. |
| Q35176439 | The TLR7 agonist induces tumor regression both by promoting CD4⁺T cells proliferation and by reversing T regulatory cell-mediated suppression via dendritic cells |
| Q37728656 | The TLR7 agonists imiquimod and gardiquimod improve DC-based immunotherapy for melanoma in mice |
| Q37286686 | The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice |
| Q26851526 | The Yin and Yang of Toll-like receptors in cancer |
| Q33734148 | The adaptor molecule MyD88 activates PI-3 kinase signaling in CD4+ T cells and enables CpG oligodeoxynucleotide-mediated costimulation. |
| Q50521448 | The adjuvant effect of TLR agonists on CD4(+) effector T cells is under the indirect control of regulatory T cells. |
| Q57704152 | The cellular prion protein is preferentially expressed by CD4+ CD25+ Foxp3+ regulatory T cells |
| Q49343115 | The choice of linker for conjugating R848 to inactivated influenza virus determines the stimulatory capacity for innate immune cells |
| Q41585090 | The contribution of direct TLR signaling to T cell responses. |
| Q37959968 | The dendritic cell-regulatory T lymphocyte crosstalk contributes to tumor-induced tolerance |
| Q27001581 | The effects of TLR activation on T-cell development and differentiation |
| Q35058213 | The emergence of immunomodulation: combinatorial immunochemotherapy opportunities for the next decade. |
| Q34132804 | The future potential for cocaine vaccines |
| Q37863856 | The immunomodulatory properties of the CD5 lymphocyte receptor in health and disease. |
| Q37214491 | The multiple facets of toll-like receptors in transplantation biology |
| Q39285665 | The myeloid differentiation factor 88 (MyD88) is required for CD4+ T cell effector function in a murine model of inflammatory bowel disease. |
| Q35207756 | The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies |
| Q36844715 | The perfect mix: recent progress in adjuvant research |
| Q30425111 | The present and future of peptide vaccines for cancer: single or multiple, long or short, alone or in combination? |
| Q37319760 | The receptor S1P1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR. |
| Q37272092 | The role of T-regulatory cells and Toll-like receptors in the pathogenesis of human inflammatory bowel disease |
| Q35288072 | The role of TLR8 signaling in acute myeloid leukemia differentiation |
| Q38213215 | The role of Toll-like receptors and vitamin D in diabetes mellitus type 1--a review |
| Q38020491 | The role of innate immune signals in antitumor immunity |
| Q33631986 | The role of regulatory T cells in cancer |
| Q37452411 | The role of tregs in glioma-mediated immunosuppression: potential target for intervention. |
| Q40107397 | Therapeutic dendritic cell vaccination with Ag coupled to cholera toxin in combination with intratumoural CpG injection leads to complete tumour eradication in mice bearing HPV 16 expressing tumours |
| Q34527281 | Therapeutic opportunities for manipulating T(Reg) cells in autoimmunity and cancer |
| Q36718548 | Therapeutic use of Aldara in chronic myeloid leukemia |
| Q95272124 | Thymic Function Associated With Cancer Development, Relapse, and Antitumor Immunity - A Mini-Review |
| Q37416211 | Toll gates to periodontal host modulation and vaccine therapy |
| Q33266015 | Toll like receptors and acute allograft rejection |
| Q91558915 | Toll-Like Receptor 8 Agonist GS-9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis B |
| Q99549625 | Toll-Like Receptor as a Potential Biomarker in Renal Diseases |
| Q89587299 | Toll-Like Receptors Signaling in the Tumor Microenvironment |
| Q64936222 | Toll-Like Receptors as Therapeutic Targets in Central Nervous System Tumors. |
| Q26770257 | Toll-Like Receptors in the Pathogenesis of Autoimmune Diseases |
| Q89509415 | Toll-like Receptors from the Perspective of Cancer Treatment |
| Q26861234 | Toll-like Receptors in Ovarian Cancer as Targets for Immunotherapies |
| Q34264024 | Toll-like receptor 2 controls expansion and function of regulatory T cells |
| Q34557118 | Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells |
| Q51838987 | Toll-like receptor 3 is necessary for dsRNA adjuvant effects. |
| Q36884862 | Toll-like receptor 8: augmentation of innate immunity in platinum resistant ovarian carcinoma |
| Q33918509 | Toll-like receptor agonists in cancer therapy |
| Q36635059 | Toll-like receptor agonists in the treatment of chronic lymphocytic leukemia |
| Q37236946 | Toll-like receptor signaling in transplantation |
| Q37186819 | Toll-like receptor signalling on Tregs: to suppress or not to suppress? |
| Q38090669 | Toll-like receptor-expressing cells for antiallergy compound screening. |
| Q35581147 | Toll-like receptors (TLRs) in transplantation |
| Q36479113 | Toll-like receptors and graft rejection |
| Q37051007 | Toll-like receptors and immune regulation: implications for cancer therapy |
| Q36937316 | Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+ CD25+ T cells |
| Q37354939 | Toll-like receptors and their role in carcinogenesis and anti-tumor treatment. |
| Q36422953 | Toll-like receptors in central nervous system glial inflammation and homeostasis |
| Q37015536 | Toll-like receptors in defense and damage of the central nervous system |
| Q53687316 | Toll-like receptors in immunity and inflammatory diseases: Past, present, and future. |
| Q36875864 | Toll-like receptors in the skin |
| Q36253608 | Toll-like receptors in tumor immunotherapy |
| Q37203723 | Toll-like receptors: lessons to learn from normal and malignant human B cells |
| Q38025094 | Towards curative cancer immunotherapy: overcoming posttherapy tumor escape |
| Q37632479 | Translational mini-review series on Th17 cells: induction of interleukin-17 production by regulatory T cells. |
| Q27008946 | Treg functional stability and its responsiveness to the microenvironment |
| Q35609371 | Tregs and infections: on the potential value of modifying their function |
| Q40113595 | Tumor immunotherapy using bone marrow-derived dendritic cells overexpressing Toll-like receptor adaptors. |
| Q38572896 | Tumor-associated galectin-3 modulates the function of tumor-reactive T cells |
| Q36625669 | Tumor-derived γδ regulatory T cells suppress innate and adaptive immunity through the induction of immunosenescence |
| Q28116224 | Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1 |
| Q36800215 | Tumor-infiltrating γδ T lymphocytes predict clinical outcome in human breast cancer |
| Q36229384 | Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells. |
| Q64108546 | Turning the Tide Against Regulatory T Cells |
| Q34099273 | UNC93B1 physically associates with human TLR8 and regulates TLR8-mediated signaling |
| Q33850593 | Ubiquitous points of control over regulatory T cells |
| Q46301580 | Vaccine responses in newborns |
| Q54269173 | Vaccine-induced antigen-specific regulatory T cells attenuate the antiviral immunity against acute influenza virus infection. |
| Q28299036 | Vaccines for tumour prevention |
| Q35781453 | Vasohibin-1 suppresses colon cancer |
| Q40183391 | Viral RNA-Unprimed Rig-I Restrains Stat3 Activation in the Modulation of Regulatory T Cell/Th17 Cell Balance |
| Q36268422 | What is the role of regulatory T cells in the success of implantation and early pregnancy? |
| Q83364189 | [Autoimmunity. Physiological control mechanisms and pathways to autoimmune disease] |
| Q92726625 | p53-responsive TLR8 SNP enhances human innate immune response to respiratory syncytial virus |
Search more.